Article thumbnail

Serum Resistin Level in Obese Male Children

By Anis Amirhakimi, Hamdollah Karamifar, Hosein Moravej and Gholamhosein Amirhakimi

Abstract

Objectives. Resistin is a member of cysteine-rich molecules. Several studies have been carried out to determine the biological effect of resistin, nevertheless a significant number are animal studies. All the studies performed regarding the relationship between serum resistin and obesity were merely accomplished in women. To the best of our knowledge, there is no survey on the correlation of the serum resistin level and obesity in male children. The aim of the present study is to assess serum concentration of resistin in obese male children. Methods. Between June 2009 and January 2010, we enrolled 42 randomly selected obese male students (body mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-eight healthy age-matched male students with normal BMI (<85th percentile) were selected as a control group for the purpose of comparison of the serum resistin levels. Results. Serum resistin levels were measured in obese and control group. No significant difference was found between resistin levels of the 2 groups (obese: 9.21 ± 5.6 ng/mL versus normal: 9.83 ± 4.3 ng/mL; P = .582). There was no significant correlation between serum resistin level and BMI. Assessing the resistin level in male subjects was the distinct feature of our study. The outstanding finding of this research is that there is no correlation between serum resistin level and obesity. Conclusion. We have demonstrated that there is no correlation between obesity in male children and resistin level. Consequently, metabolic abnormalities of insulin resistance seen in obese male patients are not related to resistin

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3092673
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A .R .S h u l d i n e r ,R .Y a n g ,a n dD A .W .G o n g ,“ R e s i s t i n ,o b e s i t y , and insulin resistance—the emerging role of the adipocyte as an endocrine organ,” New England
  2. Adipocyte signaling and lipidhomeostasis:sequelaeofinsulin-resistantadiposetissue,”
  3. (2006). Adipocyte-derived hormones, cytokines, and mediators,”
  4. (2004). Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies,”
  5. (2002). Adiposity and diabetes,” Diabetes care,
  6. (2010). Association between adiponectin, resistin, insulin resistance, and colorectal tumors,”
  7. (2006). Etiology of insulin resistance,”
  8. (2008). i u ,Q .W a n g ,Y .B .P a n ,Z .J .G a o ,Y .F .L i u ,a n dS .H . Chen, “Effects of over-expressing resistin on glucose and lipid metabolism in mice,”
  9. (2003). K e r n ,G .B .D iG r e g o r i o ,T .L u ,N .R a s s o u l i ,a n dG . Ranganathan, “Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression,” Diabetes,v o l .5 2 ,n o .7 ,p p .
  10. (2005). K u s m i n s k i ,P .G .M c T e r n a n ,a n dS .K u m a r ,“ R o l eo f resistin in obesity, insulin resistance and Type II diabetes,”
  11. (2005). L e w a n d o w s k i ,K .S z o s l a n d ,C .O ’ C a l l a g h a n ,B .K .T a n
  12. (2010). Leptin, adiponectin and resistin concentration in obesity class I and II at Sardjito Hospital Yogyakarta,”
  13. (2002). M c T e r n a n ,P .G .M c T e r n a n ,A .L .H a r t e ,P .L .L e v i c k
  14. (2002). O.Ukkola,“Resistin—amediatorofobesity-associatedinsulin resistance or an innocent bystander?”
  15. (2000). Obesity and insulin resistance,”
  16. (2002). Ogiharaet al.,“Humoralregulation of resistin expression
  17. (2004). Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity,”
  18. (2001). S a v a g e ,C .P .S e w t e r ,E .S .K l e n ke ta l . ,“ .R e s i s t i n
  19. (2006). The endocrine function of adipose tissue: an update,”
  20. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,”
  21. (2002). The function of leptin in nutrition, weight, andphysiology,”Nutrition Reviews,vol.60,no.10,pp.S1–S14,